Davidson Kempner Capital Management »

Karyopharm Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 310k 7.36

More positions owned by Davidson Kempner Capital Management

Spdr S&p 500 Etf Tr Tr Unit Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf Russell 2000 Etf Put Option (IWM)
Alibaba Group Hldg Note 0.500% 6/1/31 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Ceridian Hcm Hldg
Uber Technologies Note 0.875%12/0 (Principal)
Confluent Note 1/15/27 (Principal)
Arko Corp (ARKO)
Redfin Corp Note 0.500% 4/0 (Principal)
Ford Mtr Note 0.0% 3/15/26 (Principal)
Echostar Corp Cl A Cl A (SATS)
Li Auto Note 0.250% 5/0 (Principal)
Snowflake Note 0% 10/0 (Principal)
Trip Com Group Note 0.750% 6/1 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Opaleye Management
Affinity Asset Advisors
Susquehanna International
Vanguard Group
Ikarian Capital
Soleus Capital Management
Adage Capital Partners GP
Davidson Kempner Capital Management
Braidwell
BlackRock
Geode Capital Management
Boothbay Fund Management
Catalio Capital Management
Avidity Partners Management

View all funds holding Karyopharm Therapeutics